亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Hepatic fibrosis influences the growth of hepatocellular carcinoma.

肝细胞癌 医学 纤维化 内科学 肝纤维化 癌症研究 肝硬化 肝纤维化 胃肠病学 肝星状细胞 肝癌 病理
作者
Shinji Osada,Masayuki Kanematsu,Hisashi Imai,Satoshi Goshima,Yasuyuki Sugiyama
出处
期刊:Hepato-gastroenterology [Thieme Medical Publishers (Germany)]
卷期号:55 (81): 184-187 被引量:7
链接
标识
摘要

Background/Aims: This study is designed to evaluate the hepatocellular carcinoma (HCC) growth under physical pressure due to fibrotic condition. Methodology: 206 patients with HCC who consulted our institute in the past 15 years were selected. The patients were separated into three or two groups according to liver function or hepatic fibrosis, respectively. The preoperative mean value of serum N-terminal procollagen type III (PIIINP) was estimated as an index of hepatic fibrosis. Results: 1) Poorly differentiated type of HCC tumor was significantly larger than the other types in cases with good-to-moderate liver function or without fibrosis. By contrast, in patients with poor liver function or fibrosis, no significant difference was found on tumor diameter (TD). 2) By contrast, although proliferating cell nuclear antigen labeling index (PCNALI) in cancer tissue was correlated with tumor diameter by simple linear regression analyses, PCNALI was consistently and significantly high in keeping with histological progression regardless of the status of liver functional or presence or absence of fibrosis. 3) The mean value of TD in intrahepatic metastasis (IM) positive cases, 45.8±5.1mm, was higher than the size in negative cases. And the mean TD in IM positive cases was significantly smaller in the cases with poor liver function and fibroses. 4). In patients with small tumor, IM was noted 34.5%, 37.0% and 43.8% in good, moderate and poor liver function group, respectively. PCNALI was significantly higher in cases with moderate-to-poor liver function group or hepatic fibrosis. Conclusions: In the cases with poor liver function or hepatic fibrosis, cell proliferation cycle might be always activated even if the tumor is small.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Orange应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
打打应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
6秒前
6秒前
大大撒发布了新的文献求助10
10秒前
15秒前
好运来完成签到 ,获得积分10
16秒前
包容仙人掌完成签到,获得积分10
17秒前
kingsunkang完成签到,获得积分10
18秒前
19秒前
23秒前
kingsunkang发布了新的文献求助20
24秒前
Jasper应助潇潇雨歇采纳,获得10
24秒前
上岸应助嘻嘻哈哈采纳,获得80
24秒前
28秒前
CodeCraft应助冷艳清炎采纳,获得10
28秒前
33秒前
丘比特应助xiaoliaikeyan采纳,获得10
34秒前
34秒前
芜湖市吴奇隆完成签到,获得积分10
35秒前
39秒前
十七七发布了新的文献求助10
40秒前
41秒前
43秒前
44秒前
44秒前
xiaoliaikeyan完成签到,获得积分10
45秒前
Traveller丁完成签到,获得积分10
49秒前
xiaoliaikeyan发布了新的文献求助10
50秒前
贠子璇发布了新的文献求助10
50秒前
嘻嘻哈哈发布了新的文献求助80
56秒前
潇潇雨歇发布了新的文献求助10
57秒前
1分钟前
1分钟前
李嘛耶完成签到,获得积分10
1分钟前
GingerF应助John_snape采纳,获得50
1分钟前
嗨嗨嗨发布了新的文献求助10
1分钟前
潇潇雨歇发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6945563
求助须知:如何正确求助?哪些是违规求助? 8630839
关于积分的说明 18306462
捐赠科研通 6381817
什么是DOI,文献DOI怎么找? 3079742
关于科研通互助平台的介绍 2121403
邀请新用户注册赠送积分活动 2056653